Daria Anisimova

Ms. Daria Anisimova

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Igor Alexandrovich MakarovIgor Alexandrovich Makarov
Igor Alexandrovich Makarov
DADaria Anisimova
Daria Anisimova
AGAlexander Gurshchenkov
Alexander Gurshchenkov
ARAnton Ryzhkov
Anton Ryzhkov
Dmitry KudlayDmitry Kudlay
Dmitry Kudlay
LMLubov Borisovna Mitrofanova
Lubov Borisovna Mitrofanova
Myocardial fibrosis is an important factor in the progression of cardiovascular diseases. However, there is still no universal lifetime method of myocardial fibrosis assessment that has a high prognostic significance. The aim of the study was to determine the significance of ventricular endomyocardial biopsies for the assessment of myocardial fibrosis and to identify the severity of myocardial fibrosis in different cardiovascular diseases. Material and Methods: Endomyocardial biopsies (EMBs) of 20 patients with chronic lymphocytic myocarditis (CM), endomyocardial fragments obtained during septal reduction of 21 patients with hypertrophic cardiomyopathy (HCM), and 36 patients with a long history of hypertensive and ischemic heart disease (HHD + IHD) were included in the study. The control group was formed from EMBs taken on 12–14 days after heart transplantation (n = 28). Also, for one patient without clinical and morphological data for cardiovascular pathology, postmortem myocardial fragments were taken from typical EMB and septal reduction sites. The relative area of fibrosis was calculated as the ratio of the total area of collagen fibers to the area of the whole biopsy. Endocardium and subendocardial fibrosis were not included in the total biopsy area. Results: The relative fibrosis area in the EMBs in the CM patient group was 5.6 [3.3; 12.6]%, 11.1 [6.6; 15.9]% in the HHD + IHD patient group, 13.4 [8.8; 16.7]% in the HCM patient group, and 2.7 [1.5; 4.6]% in the control group. When comparing the fibrosis area of the CM patients in repeat EMBs, it was found that the fibrosis area in the first EMBs was 7.6 [4.8; 12.0]%, and in repeat EMBs, it was 5.3 [3.2; 7.6]%. No statistically significant differences were found between the primary and repeat EMBs (p = 0.15). In ROC analysis, the area of fibrosis in the myocardium of 1.1% (or lower than one) was found to be highly specific for the control group of patients compared to the study patients. Conclusions: EMB in the assessment of myocardial fibrosis has a questionable role because of the heterogeneity of fibrotic changes in the myocardium.

25 August 2025 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
VZV. V. Zaitsev
V. V. Zaitsev
LOL. A. Obraztsova
L. A. Obraztsova
DADaria Anisimova
Daria Anisimova
АОА. С. Оболенский
А. С. Оболенский
Alexandr GurschenkovAlexandr Gurschenkov
Alexandr Gurschenkov
OMOlga Moiseeva
Olga Moiseeva
Aim. To compare the profile of circulating biomarkers and expression of relevant fibrosis genes in the myocardium with clinical and morphological data on the severity of myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy (HCM) who underwent septal myectomy.Materials and methods. This prospective study included 69 patients with obstructive HCM and indications for septal reduction. The results of paraclinical investigation, echocardiography, cardiac magnetic resonance imaging, histological examination, serum biomarker levels (transforming growth factor beta-1 (TGF-β1), matrix metalloproteinase-9 (MMP-9), tissue inhibitor of matrix metalloproteinases-1 (TIMP-1), galectin-3, soluble interleukin-1 receptor 4 (ST2) (sST2), C-telopeptide of type I collagen (CITP), C-terminal propeptide of type I collagen (PICP) and N-terminal propeptide of type III procollagen (PIIINP)), analysis of RNA obtained from intraoperative myocardial biopsies were assessed.Results. Increased serum levels of galectin-3, TGF-β1, sST2 and collagen synthesis markers, as well as the level of the collagen degradation marker CITP were revealed. Relationships were established between the PIIINP level and interventricular septum thickness indexed to the body surface area (p=0,049), as well as the left atrial diameter (p=0,024). An increase in the expression levels of relevant fibrosis genes, with the exception of TIMP1, was noted. An increased level of circulating PIСP was associated with an increase in the expression of galectin-3 and interleukin-1 receptor type 1 genes in the myocardium. Septal myectomy allowed revealing that patients without improvement in N-terminal pro-brain natriuretic peptide had a higher sST2 level. A negative relationship was established between the MMP9 gene expression in the myocardium and changes of the left atrial size in the long-term period after septal myectomy (p=0,032).Conclusion. The profile of circulating biomarkers is associated with the expression of relevant fibrosis genes in the myocardium and is a promising non-invasive method for assessing the activity of fibrosis processes. Myocardial fibrosis plays an important role in assessing the prognosis during the follow-up of patients with HCM.